Stay updated on Tepotinib Phase II Clinical Trial

Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib Phase II Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s displayed software/content “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a release/version change without altering the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-27T09:31:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added revisions dated 2026-04-13, 2026-03-23, and 2026-03 with Revision: v3.5.2, and removed revisions dated 2025-12-23, 2025-12-04, and 2025-12 with Revision: v3.5.0. The changes pertain to the site's revision history and do not affect the study page content.
    Difference
    0.1%
    Check dated 2026-04-20T05:49:39.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Padua, Italy was replaced with Padova, Italy in the study locations.
    Difference
    0.1%
    Check dated 2026-04-06T02:44:23.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Naples, Italy was added as a location and Napoli, Italy was removed; the revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T18:16:33.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-08T04:55:07.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:38:40.000Z thumbnail image

Stay in the know with updates to Tepotinib Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.